Management of Rare Kidney TumorsJul 29, 2014 - 01:55What puts you at risk for inherited kidney cancer? Dr. Nizar Tannir discusses the signs doctors look for...View more
Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation?Jul 27, 2014 - 05:28The doctors discuss the circumstances under which small cell lung cancer patients should receive prophyla...View more
NanoString Treatment for Kidney CancerJul 24, 2014 - 02:03NanoString Technology may help doctors learn what is driving tumor growth in kidney cancer patients and,...View more
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?Jul 22, 2014 - 02:27Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lu...View more
How is the Heng Criteria Applied to Kidney Cancer Patients?Jul 20, 2014 - 04:40Dr. Daniel Heng is the namesake of the Heng Criteria, which evaluates various factors of kidney cancer pa...View more
Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment?Jul 17, 2014 - 07:28The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab...View more
What is PD1 and PDL1 in Kidney Cancer?Jul 15, 2014 - 03:15Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and h...View more
Zykadia for ALK Positive Lung Cancer: New Drug, New HopeJul 13, 2014 - 07:22The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib),...View more